Literature DB >> 3754537

Familial isolated aniridia associated with a translocation involving chromosomes 11 and 22 [t(11;22)(p13;q12.2)].

J W Moore, S Hyman, S E Antonarakis, E H Mules, G H Thomas.   

Abstract

Isolated aniridia segregated as an autosomal dominant trait in a family with 11 affected members spanning five generations. Four of the eight individuals studied had aniridia associated with glaucoma and cataracts. Cytogenetic studies revealed an apparently balanced reciprocal translocation between chromosomes 11 and 22 [t(11;22)(p13;q12.2)], while four unaffected relatives had normal karyotypes. There is no evidence of Wilms tumor or genitourinary abnormalities in any members of the family. Restriction enzyme analysis of the human catalase gene revealed no abnormalities in the individuals with the translocation. A summary of phenotypic abnormalities in 61 cases associated with aniridia is presented, as well as a comparison of breakpoints in 44 cases of 11p deletion. These data indicate that single breaks at 11p13 are associated with isolated aniridia, while deletion of 11p13 results in aniridia combined with Wilms tumor, genitourinary abnormalities, and/or mental retardation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3754537     DOI: 10.1007/bf00290952

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  39 in total

1.  Cancer chromosome breakpoints and common fragile sites induced by aphidicolin.

Authors:  F Hecht; T W Glover
Journal:  Cancer Genet Cytogenet       Date:  1984-10

2.  Familial occurrence of the aniridia-Wilms tumor syndrome with deletion 11p13-14.1.

Authors:  J J Yunis; N K Ramsay
Journal:  J Pediatr       Date:  1980-06       Impact factor: 4.406

3.  Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13.

Authors:  U Francke; L B Holmes; L Atkins; V M Riccardi
Journal:  Cytogenet Cell Genet       Date:  1979

4.  Association of del(11)(p15.1p12), aniridia, catalase deficiency, and cardiomyopathy.

Authors:  S Gilgenkrantz; C Vigneron; M J Gregoire; C Pernot; A Raspiller
Journal:  Am J Med Genet       Date:  1982-09

5.  Aniridia, male pseudohermaphroditism, gonadoblastoma, mental retardation, and del 11p13.

Authors:  C Turleau; J de Grouchy; J L Dufier; L H Phuc; P H Schmelck; R Rappaport; C Nihoul-Fékété; N Diebold
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

6.  Regional mapping of catalase and Wilms tumor--aniridia, genitourinary abnormalities, and mental retardation triad loci to the chromosome segment 11p1305----p1306.

Authors:  K Narahara; K Kikkawa; S Kimira; H Kimoto; M Ogata; R Kasai; M Hamawaki; K Matsuoka
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Autosomal dominant aniridia: probable linkage to acid phosphatase-1 locus on chromosome 2.

Authors:  R E Ferrell; A Chakravarti; H M Hittner; V M Riccardi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

8.  Chromosome abnormalities involving 11p13 and low erythrocyte catalase activity.

Authors:  N Niikawa; Y Fukushima; N Taniguchi; S Iizuka; T Kajii
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

9.  Aniridia. A review.

Authors:  L B Nelson; G L Spaeth; T S Nowinski; C E Margo; L Jackson
Journal:  Surv Ophthalmol       Date:  1984 May-Jun       Impact factor: 6.048

10.  Catalase levels in patients with aniridia and/or Wilms' tumor: utility and limitations.

Authors:  R E Ferrell; V M Riccardi
Journal:  Cytogenet Cell Genet       Date:  1981
View more
  19 in total

1.  The QM gene is X-linked and therefore not involved in suppression of tumorigenesis in Wilms' tumor.

Authors:  A M van den Ouweland; M Verdijk; M M Mannens; B A van Oost
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

2.  Somatic cell hybrid and long-range physical mapping of 11p13 microdissected genomic clones.

Authors:  L M Davis; G Senger; H J Lüdecke; U Claussen; B Horsthemke; S S Zhang; B Metzroth; K Hohenfellner; B Zabel; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  A deletion map of the WAGR region on chromosome 11.

Authors:  M Gessler; G H Thomas; P Couillin; C Junien; B C McGillivray; M Hayden; G Jaschek; G A Bruns
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

4.  De novo t(2;13)(p24.3;q14.2) and retinoblastoma. Mapping of two 13q14 probes by in situ hybridization.

Authors:  V Blanquet; C Turleau; N Créau-Goldberg; C Cochet; J de Grouchy
Journal:  Hum Genet       Date:  1987-05       Impact factor: 4.132

Review 5.  Mendelian cytogenetics. Chromosome rearrangements associated with mendelian disorders.

Authors:  N Tommerup
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

6.  Molecular analysis of chromosome region 11p13 in patients with Drash syndrome.

Authors:  L Jadresic; R B Wadey; B Buckle; T M Barratt; C D Mitchell; J K Cowell
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

7.  FISH studies in a patient with sporadic aniridia and t(7;11) (q31.2;p13).

Authors:  J A Crolla; I Cross; N Atkey; M Wright; C A Oley
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

8.  Characterization of a panel of somatic cell hybrids for subregional mapping along 11p and within band 11p13. Subdivision of the WAGR complex region.

Authors:  P Couillin; M Azoulay; I Henry; N Ravisé; M C Grisard; C Jeanpierre; F Barichard; P Metezeau; J J Candelier; W Lewis
Journal:  Hum Genet       Date:  1989-05       Impact factor: 4.132

9.  Assignment of the human gamma-glutamyl transferase gene to the long arm of chromosome 22.

Authors:  F Bulle; M G Mattei; S Siegrist; A Pawlak; E Passage; M N Chobert; Y Laperche; G Guellaën
Journal:  Hum Genet       Date:  1987-07       Impact factor: 4.132

10.  Detection of a cryptic paracentric inversion within band 11p13 in familial aniridia by fluorescence in situ hybridization.

Authors:  Y Fukushima; J Hoovers; M Mannens; K Wakui; H Ohashi; T Ohno; Y Ueoka; N Niikawa
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.